Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.

Shen C, Chen J, Li R, Zhang M, Wang G, Stegalkina S, Zhang L, Chen J, Cao J, Bi X, Anderson SF, Alefantis T, Zhang M, Cai X, Yang K, Zheng Q, Fang M, Yu H, Luo W, Zheng Z, Yuan Q, Zhang J, Wai-Kuo Shih J, Kleanthous H, Chen H, Chen Y, Xia N.

Sci Transl Med. 2017 Oct 18;9(412). pii: eaam5752. doi: 10.1126/scitranslmed.aam5752.

PMID:
29046433
2.

Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes.

Kalnin K, Chivukula S, Tibbitts T, Yan Y, Stegalkina S, Shen L, Cieszynski J, Costa V, Sabharwal R, Anderson SF, Christensen N, Jagu S, Roden RBS, Kleanthous H.

Vaccine. 2017 Sep 5;35(37):4942-4951. doi: 10.1016/j.vaccine.2017.07.086. Epub 2017 Aug 1.

3.

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.

Schotsaert M, Ysenbaert T, Smet A, Schepens B, Vanderschaeghe D, Stegalkina S, Vogel TU, Callewaert N, Fiers W, Saelens X.

Sci Rep. 2016 Apr 13;6:24402. doi: 10.1038/srep24402.

4.

Correction for Lam et al., antibodies to PhnD inhibit staphylococcal biofilms.

Lam H, Kesselly A, Stegalkina S, Charlebois RL, Oomen R, Kleanthous H, Yethon JA.

Infect Immun. 2015 May;83(5):2197. doi: 10.1128/IAI.00285-15. No abstract available.

5.

Antibodies to PhnD inhibit staphylococcal biofilms.

Lam H, Kesselly A, Stegalkina S, Kleanthous H, Yethon JA.

Infect Immun. 2014 Sep;82(9):3764-74. doi: 10.1128/IAI.02168-14. Epub 2014 Jun 23. Erratum in: Infect Immun. 2015 May;83(5):2197.

6.

Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.

Kalnin K, Tibbitts T, Yan Y, Stegalkina S, Shen L, Costa V, Sabharwal R, Anderson SF, Day PM, Christensen N, Schiller JT, Jagu S, Roden RB, Almond J, Kleanthous H.

Vaccine. 2014 Jun 12;32(28):3540-7. doi: 10.1016/j.vaccine.2014.04.032. Epub 2014 Apr 26.

7.

High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.

Mundle ST, Hernandez H, Hamberger J, Catalan J, Zhou C, Stegalkina S, Tiffany A, Kleanthous H, Delagrave S, Anderson SF.

PLoS One. 2013;8(2):e57224. doi: 10.1371/journal.pone.0057224. Epub 2013 Feb 26.

8.

Gene expression profiling of potato responses to cold, heat, and salt stress.

Rensink WA, Iobst S, Hart A, Stegalkina S, Liu J, Buell CR.

Funct Integr Genomics. 2005 Oct;5(4):201-7. Epub 2005 Apr 22.

PMID:
15856349
9.

Comparative analyses of potato expressed sequence tag libraries.

Ronning CM, Stegalkina SS, Ascenzi RA, Bougri O, Hart AL, Utterbach TR, Vanaken SE, Riedmuller SB, White JA, Cho J, Pertea GM, Lee Y, Karamycheva S, Sultana R, Tsai J, Quackenbush J, Griffiths HM, Restrepo S, Smart CD, Fry WE, Van Der Hoeven R, Tanksley S, Zhang P, Jin H, Yamamoto ML, Baker BJ, Buell CR.

Plant Physiol. 2003 Feb;131(2):419-29.

10.

cDNA array analysis of gene expression following hemorrhagic shock and resuscitation in rats.

Alam HB, Stegalkina S, Rhee P, Koustova E.

Resuscitation. 2002 Aug;54(2):195-206.

PMID:
12161300
11.

Effects of lactated Ringer's solutions on human leukocytes.

Koustova E, Stanton K, Gushchin V, Alam HB, Stegalkina S, Rhee PM.

J Trauma. 2002 May;52(5):872-8.

PMID:
11988652
12.

Cytokine expression profiling in human leukocytes after exposure to hypertonic and isotonic fluids.

Gushchin V, Stegalkina S, Alam HB, Kirkpatrick JR, Rhee PM, Koustova E.

J Trauma. 2002 May;52(5):867-71.

PMID:
11988651
13.

pTAR-encoded proteins in plasmid partitioning.

Kalnin K, Stegalkina S, Yarmolinsky M.

J Bacteriol. 2000 Apr;182(7):1889-94.

14.

Supplemental Content

Loading ...
Support Center